ARCHITECT AFP 03P36-30

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2017-01-16 for ARCHITECT AFP 03P36-30 manufactured by Abbott Ireland.

Event Text Entries

[64917064] An evaluation is in process. A follow-up report will be submitted when the evaluation is complete.
Patient Sequence No: 1, Text Type: N, H10


[64917125] The customer stated that the architect analyzer generated falsely elevated afp results on one patient. The results provided were: initial 993. 96 / repeated = 3. 21. There was no reported impact to patient management. There was no additional patient information provided.
Patient Sequence No: 1, Text Type: D, B5


[73009839] The customer observed a single false elevated afp result using architect afp, list 3p36-30, lot 64393fn00. No patient sample was available to assist in the investigation. The complaint text states that the customer measured afp for a patient who was not diagnosed with testicular cancer or was at 15 to 21 weeks gestation. The information provided indicates that the afp assay was used for screening which was not in alignment with the afp assay labeling. Historical performance of list 3p36 was evaluated using world wide data from abbott link. The patient data was analyzed and compared to an established control limit. This evaluation indicated that the patient median result for lot 64393fn00 is within the established control limits and no unusual reagent lot performance was identified. No adverse trend was identified for the customer's issue. A review of complaints determined that there is no unusual complaint activity for lot 64393fn00. Accuracy testing was performed with a file sample of lot 64393fn00 and a serum based panel sample and all specifications were met indicating that lot 64393fn00 is performing acceptably. A review of the manufacturing records for this lot did not identify any issues associated with the customer observation. A review of assay labeling and the architect operations manual shows adequate information is provided to address discrepant results including sample integrity/ sample handling issues. Based on the investigation no product deficiency was identified. A malfunction was identified as the device failed to meet performance specifications or otherwise perform as intended at the customer site.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3008344661-2017-00004
MDR Report Key6253088
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2017-01-16
Date of Report2017-04-03
Date of Event2016-12-22
Date Mfgr Received2017-03-29
Device Manufacturer Date2016-06-16
Date Added to Maude2017-01-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224667-512
Manufacturer G1ABBOTT IRELAND
Manufacturer StreetDIAGNOSTICS DIVISION FINISKLIN BUSINESS PARK
Manufacturer CitySLIGO NA
Manufacturer CountryEI
Manufacturer Postal CodeNA
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameARCHITECT AFP
Generic NameALPHA-FETOPROTEIN
Product CodeLOK
Date Received2017-01-16
Catalog Number03P36-30
Lot Number64393FN00
Device Expiration Date2017-05-25
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT IRELAND
Manufacturer AddressDIAGNOSTICS DIVISION FINISKLIN BUSINESS PARK SLIGO NA EI NA


Patients

Patient NumberTreatmentOutcomeDate
10 2017-01-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.